CC Shareholder Alert: The Chemours Company Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
Important Notice Regarding Alleged Opteon Aftermarket Demand Misrepresentations. The lawsuit claims that record 2025 refrigerant sales reflected an overfilled distribution channel, which set up a 2026 sales decline for Chemours shareholders. NEW YORK, Nov. 11, 2026 /PRNewswire/ -- Levi &...
Covered in this story
Analyst targets on Chemours
- RBC Capital Markets: at $13.4 · target $14 by Oct 2027 · Sector Perform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Chemours →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.